Finance
AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push
June 22 (Reuters) - AbbVie said on Monday it would buy biotech Apogee Therapeutics for $10.9 billion...
22nd June, 2026
Biotech
Latest articles
Finance
Swiss Biotech sector boosted by shift toward private funding, report says
By Marleen Kaesebier BASEL, Switzerland, May 5 (Reuters) - Switzerland's biotech industry shifted to...
5th May, 2026
Finance
CureVac sues Moderna for patent infringement over COVID-19 vaccines
By Blake Brittain April 24 (Reuters) - German biotech company CureVac sued Moderna in Delaware feder...
24th April, 2026
Finance
Evotec vows to further engage with investor MAK, who demanded change
FRANKFURT, April 7 - Evotec said on Tuesday it would continue a dialogue with investor MAK Capital,...
7th April, 2026
Finance
FDA tells uniQure early trial data insufficient for brain disorder therapy filing
March 2 (Reuters) - UniQure said on Monday the U.S. health regulator has informed the company that d...
2nd March, 2026
Finance
EU regulator backs approval for Moderna's combined COVID and flu vaccine
By Bhanvi Satija Feb 27 (Reuters) - Europe's medicines regulator recommended approval for Moderna's...
27th February, 2026
Finance
Eli Lilly's weight-loss pill shows higher side effects than Novo rival in diabetes trial
Feb 26 (Reuters) - Eli Lilly on Thursday released new data from a head-to-head trial of its experime...
26th February, 2026
Finance
Novo Nordisk partners with Vivtex in up to $2.1 billion deal for oral obesity drugs
Feb 25 (Reuters) - Danish drugmaker Novo Nordisk has partnered with U.S.-based Vivtex Corp in a deal...
25th February, 2026
Finance
EQT backs out of takeover bid for UK's Oxford Biomedica
Feb 25 (Reuters) - Private equity group EQT said on Wednesday it had decided not to proceed with a t...
25th February, 2026
Finance
Novartis to build radioligand therapy site in Texas to expand US manufacturing
Feb 25 (Reuters) - Novartis said on Wednesday it intends to build a radioligand therapy manufacturin...
25th February, 2026
Finance
GSK to buy 35Pharma for $950 million in CEO Miel's second major deal
Feb 25 (Reuters) - GSK on Wednesday agreed to pay $950 million in cash for Canadian biopharmaceutica...
25th February, 2026
Finance
Barclays slashes sales forecasts for Novo's CagriSema by more than 80%
By Maggie Fick LONDON, Feb 24 (Reuters) - Barclays analysts on Tuesday slashed their peak sales fore...
24th February, 2026